2026 NPPES data Specialist NPI 1821094947 M.D.
Verify on CMS →

MARK SCHOENFELD, M.D.

Specialist in NEW HAVEN, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 369 beneficiaries · Specialist avg: 1K
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
73.5637/100
▼ 10 pts below national avg 83.1 · [object Object]
What the federal data reveals: MARK SCHOENFELD, M.D. is a Specialist ([object Object]) practicing in NEW HAVEN, Connecticut with a Medicare Part D prescribing footprint of 2K claims across 369 beneficiaries — 36% brand-name prescribing . Their CMS MIPS Final Score of 73.5637/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What the federal data shows

MARK SCHOENFELD, M.D. reported a CMS MIPS final score of 73.5637/100 — below the 83.1 national average — and filed 1,744 Medicare Part D claims in 2023.

73.5637/100
MIPS score · -10 vs avg
2K
Part D claims, 2023
64%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK SCHOENFELD, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

74 11th percentile higher than 11% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

MARK SCHOENFELD, M.D. at a glance

Below national average

NPI registry status

Active

Issued 06/23/2005

NPI 1821094947

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

1,744 18% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

73.5637/100 9.536299999999997% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Connecticut

How Specialist compares to other specialties among Connecticut providers

Connecticut providers

Specialist share within Connecticut

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Connecticut

Medicare quality performance — MIPS

MARK SCHOENFELD, M.D.'s 2023 MIPS final score plotted against the Specialist national average

Below national average
MIPS Final Score
73.5637/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 73.5637/100 vs national avg 83.1

0%100%National avg83%73.6%
MIPS final score (Specialist) — 73.5637/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK SCHOENFELD, M.D. is a Specialist provider practicing in NEW HAVEN, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1821094947. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK SCHOENFELD, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 330 ORCHARD ST, NEW HAVEN, CT, 06511, with a listed phone of (203) 867-5400. NPI 1821094947 was issued on 06/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHOENFELD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,744 prescription claims written by this provider, covering 369 Medicare beneficiaries and totaling roughly $879K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.5637/100 for the 2023 performance year (Quality 75.8435, Cost 51.4318), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

330 ORCHARD ST
NEW HAVEN, CT 06511

Provider Details

NPI 1821094947
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 06/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

73.5637
Final Score
Avg: 83.1
75.8435
Quality
51.4318
Cost
74
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK SCHOENFELD, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

YALE UNIVERSITY
GUILFORD, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

MARK SCHOENFELD, M.D. — brand share 36.0%
Specialty average (est.)

36% brand-name claims vs 64% generic, on 1,744 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,744
Total Claims
$879K
Total Drug Cost
369
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,538
Total Day Supply
135,426
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$799K
Generic Drug Cost
$80K

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
1.69
Gender Split
40% female / 60% male
Age Distribution
<65: 24, 65-74: 116, 75-84: 169, 85+: 60

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eliquis
Apixaban
407
Metoprolol Succinate
211
Flecainide Acetate
122
Xarelto
Rivaroxaban
112
Diltiazem 24hr Er (Cd)
Diltiazem Hcl
106
Mexiletine Hcl
80
Metoprolol Tartrate
74
Amiodarone Hcl
69
Multaq
Dronedarone Hcl
50
Furosemide
43

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How MARK SCHOENFELD, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

MARK SCHOENFELD, M.D.'s 1,744 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as SCHOENFELD.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK SCHOENFELD, M.D.'s specialty?
MARK SCHOENFELD, M.D. specializes in Specialist and practices in NEW HAVEN, Connecticut. Credentials: M.D..
How much does MARK SCHOENFELD, M.D. prescribe under Medicare Part D?
In 2023, MARK SCHOENFELD, M.D. wrote 1,744 Medicare Part D claims totaling $879K in drug costs for 369 beneficiaries.
What is MARK SCHOENFELD, M.D.'s Medicare quality score?
MARK SCHOENFELD, M.D. has a CMS MIPS Final Score of 73.5637/100 (Quality: 75.8435, Cost: 51.4318). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK SCHOENFELD, M.D. located?
MARK SCHOENFELD, M.D. is located at 330 ORCHARD ST, NEW HAVEN, CT, 06511. Phone: (203) 867-5400.
What is MARK SCHOENFELD, M.D.'s NPI number?
MARK SCHOENFELD, M.D.'s National Provider Identifier (NPI) is 1821094947, issued on 06/23/2005.
Does MARK SCHOENFELD, M.D. prescribe more brand-name or generic drugs?
MARK SCHOENFELD, M.D.'s prescribing is 36% brand-name and 64% generic drugs by claim count, with $799K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does MARK SCHOENFELD, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK SCHOENFELD, M.D.'s most frequently prescribed drugs include Eliquis, Metoprolol Succinate, Flecainide Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK SCHOENFELD, M.D. accept Medicare?
MARK SCHOENFELD, M.D. appears in CMS Medicare data with 1,744 Part D claims and 369 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK SCHOENFELD, M.D.'s credentials?
MARK SCHOENFELD, M.D.'s NPI is 1821094947 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology